– USA, NJ – Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced the election of President and CEO, Jim Davis, to the additional role of Chairman of the Board of Directors, effective April 1, 2023, to succeed Steve Rusckowski.
“The Board carefully considered our governance structure and determined that combining the roles of Chairman and CEO under Jim Davis’s leadership is in the best interest of shareholders to successfully continue to execute Quest Diagnostics’ strategy,” said Lead Independent Director, Tim Ring.
About James E. Davis
Jim Davis is Chief Executive Officer and President of Quest Diagnostics, a role he assumed on November 1, 2022, after a gradual leadership transition plan, succeeding Quest’s long-time CEO Steve Rusckowski.
Previously, Jim served as Executive Vice President for General Diagnostics since 2017. Jim joined Quest in April 2013 as Senior Vice President, Diagnostic Services, and was named Senior Vice President, Operations in February 2014.
Before joining Quest, Jim served as CEO of InSightec, Inc., a medical device company. Before that, he held senior management positions in a two-decade career in General Electric’s aviation and healthcare businesses, including leading GE’s MRI business for five years. Before GE, Jim led the development of strategic and operating initiatives for clients of McKinsey & Company, Inc. He holds a master’s degree in management from the Sloan School of Management at Massachusetts Institute of Technology, a master’s degree in science from MIT and a bachelor’s degree in aeronautical engineering from the University of Michigan.
“I am honored to assume these additional responsibilities as I continue to work together with the Board, Quest’s nearly 50,000 colleagues, and our many customers and partners to create a healthier world and build value,” said Jim Davis.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
For more information: https://www.questdiagnostics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.